Ublituximab (TGTX-1101), A Novel Anti-CD20 Monoclonal Antibody (mAb), Demonstrates Activity in Rituximab-sensitive and Rituximab–resistant B Non-Hodgkin Lymphoma (B-NHL) Pre-clinical In Vitro and In Vivo Models.

Drug Category : Array
Conference Category : Array
Lead Author : Barth M, Czuczman M, et al.
Published Date : 11/12/2012
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2020/08/ASH-2012-TG-1101-Roswell-FINAL.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top